Colton Center for Autoimmunity

Colton Center for Autoimmunity

Funds Yale investigators in autoimmune and allergic disease to expand discovery-stage biomedical research.

The Colton Center for Autoimmunity, administered through Yale Ventures, funds investigator-initiated translational research focused on autoimmune and allergic diseases. The centre operates as part of the Yale Ventures accelerator fund portfolio and provides research grants to Yale faculty principal investigators. In 2024 the programme made eleven awards, and in 2023 it made seven awards, demonstrating consistent annual activity since the centre's establishment. Specific dollar amounts per award are not published on the programme landing page; prospective applicants are directed to contact Makoto Yoshioka, PhD (Operational Director) at makoto.yoshioka@yale.edu or 203-343-2868.

Eligibility is restricted to Yale faculty principal investigators; external organisations, individuals, and non-Yale institutions are not eligible. The research scope is limited to autoimmune and allergic disease, and projects are expected to be investigator-initiated rather than responsive to a prescribed topic list. The 2026 cycle application portal is active on the Yale Ventures website; no public deadline date has been published on the landing page. A second contact, Lolahon Kadiri, MD PhD, handles licensing and commercialisation inquiries for projects with downstream IP implications.

To compete successfully, applicants should frame their work explicitly within translational autoimmunity or allergy science — the centre does not fund adjacent disease areas. Because award amounts and review criteria are not disclosed publicly, direct outreach to the Operational Director before submission is advisable to confirm scope alignment and obtain the current award-size range. The historical award volume (eleven in 2024, seven in 2023) suggests the centre actively deploys capital each year and reviews proposals on a defined annual cycle even when exact deadlines are unstated.